Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

12 Dec 2008 11:00

RNS Number : 0326K
Gleeson(M J)Group PLC
12 December 2008
 



12 December 2008

M J GLEESON GROUP PLC

Board Changes

Resignation of Paul Wallwork as Group Chief Executive

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces the resignation of Paul Wallwork as Group Chief Executive with effect from 31 December 2008

Paul Wallwork, ACA, BA (Hons), 46, was appointed to the Board in January 2006 as Group Finance Director. He was appointed Group Chief Executive in January 2007 having previously served as Interim Group Chief Executive since July 2006. He previously held senior financial and management roles with Inchcape plc and senior financial roles with Brent International plc.

Dermot Gleeson, Non-executive Chairman, stated "I would like to thank Paul for his strong and energetic leadership of the Gleeson Group through an extremely challenging period. He has ensured that the Group is well placed to meet the tough challenges faced by all housebuilders in the current market conditions."

Appointment of Group Chief Executive

Gleeson is pleased to announce the appointment as Group Chief Executive, with effect from 1 January 2009, of Chris Holt who, since 1 May 2007, has been Group Finance Director and prior to that held the position of Interim Group Finance Director from August 2006.

Nicholas Christopher Holt, BSc, MBA, CIMA, 57, has obtained a wealth of financial and management experience at senior level with internationally renowned businesses, namely Foster Wheeler (1987-2005) and Bechtel (1975-87). 

Dermot Gleesonstated "As Group Finance Director, Chris has made a hugely important contribution to the successful restructuring of the Group, and his skills and experience mean that he is very well equipped to provide the effective leadership that Gleeson will continue to need in an exceptionally difficult economic environment."

Appointment of Group Finance Director

To replace Chris Holt, Gleeson is pleased to announce the appointment of Alan Martin as Group Finance Director with effect from 1 January 2009. Alan is currently Group Financial Controller, a position he has held since November 2006.

Alan Martin, BSc (Hons), ACA, 42, qualified as a Chartered Accountant in 1990, following which he joined Price Waterhouse where he specialised in corporate recovery in both London and SydneyAustralia. Assignments included secondment as Advisor to National Australia Bank. In 2000, he joined Psion PLC, where he held a number of senior management roles, the most recent being Group Financial Controller.

Alan Martin has held no directorship in any other publicly quoted company at any time in the previous five years and there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules.

Dermot Gleeson stated "I am delighted that Alan has joined the Board to which he has the potential to make an extremely valuable contribution." 

Enquiries:

M J Gleeson Group plc 01252 360300

Chris Holt (Group Chief Executive, Designate)

Alan Martin (Group Finance Director, Designate)

Bankside Consultants Limited

Charles Ponsonby  020 7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKBKNKBDDFBD
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.